EGFR and cancer: In malignant ovarian tumors, cancer cells growth and survival is induced by autocrine and paracrine stimulation of EGFR and its overexpression and hyperactivity is associated with resistance to anticancer treatments; moreover, activation of the EGFR receptor is associated with sprouting of metastases [12].